News - MedImmune

Filter

Current filters:

MedImmune

Popular Filters

iBio uses iBioLaunch technology to produce functional MAb copy of Synagis

11-04-2012

US biotech firm iBio (NYSE AMEX: IBIO) says that its proprietary iBioLaunch technology for the production…

AstraZenecaBiotechnologyiBIOMedImmunePalivizumabResearchRespiratory and PulmonarySynagis

Further $100 million committed to AstraZeneca’s MedImmune Ventures

29-11-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed yesterday that it has committed an additional…

AstraZenecaFinancialMedImmuneMergers & AcquisitionsPharmaceutical

AgonOx partners with AstraZeneca unit for development of OX40 agonists in cancer therapy

02-11-2011

USA-based AgonOx has entered into an exclusive global partnership with MedImmune, the global biologics…

AgonOxAstraZenecaBiotechnologyLicensingMedImmuneOncologyPharmaceuticalResearch

AstraZeneca unit in-licenses Pfizer drug candidate tremelimumab

04-10-2011

Anglo-Swedish drug major AstraZeneca’s (LSE: AZN) US biologics subsidiary MedImmune has in-licensed…

AstraZenecaLicensingMedImmuneOncologyPfizerPharmaceutical

UK Judge denies AstraZeneca/MedImmune patent rights

07-07-2011

The High Court this week ruled that Anglo-Swedish drug major AstraZeneca (LSE: AZN) subsidiary MedImmune’s…

AstraZenecaBiotechnologyEuropeLucentisMedImmuneNovartisOphthalmicsPatentsPharmaceuticalRoche

Company Spotlight

Fibrotech

Fibrotech

Back to top